CEBPZ and acute myeloid leukemia: A systematic review of studies of CBF AML patients reported c-kit mutations in 10.9–46.2% of patients, with a mean of 31%; the authors concluded that c-kit mutations may indicate a poor prognosis in t(8;21) [176].